Prospective observational study of Anamorelin in pancreatic cancer patients with cancer cachexia

Prospective observational study of Anamorelin in pancreatic cancer patients with cancer cachexia - Analysis of effect of Anamorelin for pancreatic cancer cachexia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047457

Enrollment

Registered

2022-04-11

Start date

2021-09-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients appropriate for anamorelin Patients with unresectable pancreatic cancer and relapse after surgery

Exclusion criteria

Exclusion criteria: Patients with arrhythmia, heart failure, and ischemic heart disease Patients with uncontrolled diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Improvement of body weight and skeletal muscle mass	—

Secondary

Measure	Time frame
Improvement of Quality of life and Survival rate	—

Countries

Japan

Contacts

Public Contactreina yokoo

National Hospital Organization Kure Medical Center and Chugoku Cancer Center IRB

506-chiken@mail.hosp.go.jp0823-22-3111

Outcome results